Morepen Laboratories Ltd. (MOREPENLA): Morepen Laboratories Share Price near 52-week high even as stock trades slightly lower

Morepen Laboratories Share Price was Rs 120.15, down 0.41% today, while staying close to its 52-week high; market capitalisation stood at Rs 6,279.55 crore.

Morepen Laboratories Share Price opened the morning near its prior settlement and was last traded at Rs 120.15, down 0.41% from the previous close of Rs 120.65. The stock remained within sight of its 52-week high, with intraday movement between Rs 118.25 and Rs 123.50, while market capitalisation stood at Rs 6,279.55 crore. That combination makes the move relevant for readers tracking Morepen Laboratories Share Price, Morepen Laboratories Share Price Today and Morepen Laboratories Stock News.

According to latest Univest data, the near 52-week high event is defined by the stock trading close to the yearly peak rather than setting a new record. Here, the market’s price action confirms proximity to that level, but it does not establish a company-specific catalyst. For investors scanning Morepen Laboratories News Today, the key point is that the share price is still trading at elevated levels relative to its recent range and still commands attention in Healthcare market updates.

Morepen Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 120.15
Previous Close	Rs 120.65
Today's Move	Rs -0.5 (-0.41%)
Open	Rs 120.65
High	Rs 123.5
Low	Rs 118.25
Turnover	Rs 8.08 crore
Market Capitalisation	Rs 6,279.55 crore

Morepen Laboratories Ltd. (MOREPENLA) traded at Rs 120.15 versus the previous close of Rs 120.65, a fall of 0.41%. The stock opened at Rs 120.65, reached a high of Rs 123.5 and touched a low of Rs 118.25.

Morepen Laboratories Share Price Today reflects a narrow day move rather than a one-directional swing. The stock opened at Rs 120.65, matched the previous close at the open, then moved through a day high of Rs 123.50 and a day low of Rs 118.25 before settling back to Rs 120.15 in live trade. Turnover stood at Rs 8.08 crore. The price remains near the one-year high zone, so the headline event is the proximity to the yearly high rather than a fresh benchmark being set.

The distance from the current price to the day high is modest, and the stock is also well above its longer-reference levels cited in the market data. For readers following Morepen Laboratories Share Price Live and Morepen Laboratories Share Price Update, the immediate question is not whether the stock has already broken out, but how it behaves while trading near the 52-week peak. The latest Unvies t figures confirm the event without assigning a cause.

That sets up the bigger question for Morepen Laboratories Stock News: what do the balance-sheet, earnings and valuation numbers say about the stock’s current standing?

Morepen Laboratories Ltd. (MOREPENLA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,279.55 crore
P/E Ratio	47.04x
P/B Ratio	5.07x
ROE	7.96%
ROCE	10.19%
EPS	Rs 2.56
Book Value Per Share	Rs 23.78
Dividend Yield	0.17%

Morepen Laboratories Ltd. (MOREPENLA) fundamental metrics show P/E 47.04x, P/B 5.07x, ROE 7.96%, ROCE 10.19%. These figures provide context only and are not a buy or sell signal.

Morepen Laboratories Ltd. has a market capitalisation of Rs 6279.55 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 47.04x, P/B at 5.07x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	47.04x
Benchmark Median P/E	28.19x
Benchmark Average P/E	37.51x
Benchmark P/E Range	0x to 417.17x
Company P/B Ratio	5.07x
Benchmark Median P/B	3.08x
Company ROE	7.96%
Benchmark Median ROE	11.78%
Company ROCE	10.19%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 6,279.55 crore
Benchmark Median Market Cap	Rs 733.35 crore

Morepen Laboratories Ltd. (MOREPENLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Morepen Laboratories Ltd. (MOREPENLA) has a P/E ratio of 47.04x, which is above the benchmark median of 28.19x, a difference of +66.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Morepen Laboratories Ltd. (MOREPENLA) has a ROE of 7.96%, which is below the benchmark median of 11.78%, a difference of -32.43%. Morepen Laboratories Ltd. (MOREPENLA) has a ROCE of 10.19%, which is below the benchmark median of 13.65%, a difference of -25.35%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
SENORES PHARMACEUTICALS L	SENORES	6,310.72	51.2	6.71	14.14	15.66
Innova Captab Ltd.	INNOVACAP	6,473.57	42.14	5.8	13.75	15.04
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	6,698.7	61.2	4.53	11.22	12.41
Orchid Pharma Ltd.	ORCHPHARMA	5,734.61	147.03	4.12	7.86	8.05
FDC Ltd.	FDC	5,699.98	19.53	2.18	11.81	15.93

Morepen Laboratories Ltd. (MOREPENLA) has a P/E ratio of 47.04x compared with the displayed peer median of 51.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.96% compares with a peer median of 11.81% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLA) has a market capitalisation of Rs 6,279.55 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

• Morepen Laboratories Share Price is trading close to its 52-week high while the day move is -0.41%.
• The current price is Rs 120.15, compared with the previous close of Rs 120.65.
• Turnover stood at Rs 8.08 crore during the latest trading window.
• The company’s P/E of 47.04 and P/B of 5.07 sit above the industry median.
• ROE at 7.96% and ROCE at 10.19% sit below the industry median in the same industry set.

About Morepen Laboratories

Morepen Laboratories Ltd. operates in Healthcare and is classified under Pharmaceuticals & Drugs. The company’s market data places it in the spotlight for Morepen Laboratories Company News and Morepen Laboratories Latest News because the share price is trading near a 52-week high. The latest Univest data also shows revenue of Rs 5,701.56 and book value per share of Rs 23.78. Morepen Laboratories Share News therefore combines a near-peak price event with a detailed financial backdrop.

Frequently Asked Questions

Why is Morepen Laboratories Share Price in focus today?

Ans. Morepen Laboratories Share Price is in focus because it is trading close to its 52-week high. The latest price is Rs 120.15, and the stock remains a notable Healthcare market update.

What is Morepen Laboratories Share Price Today?

Ans. Morepen Laboratories Share Price Today is Rs 120.15. It is down 0.41% from the previous close of Rs 120.65, while trading within a narrow band during the latest market window.

How close is Morepen Laboratories Share Price to its 52-week high?

Ans. Morepen Laboratories Share Price is close to its 52-week high and traded as high as Rs 123.50 during the day. The event reflects proximity to the yearly peak, not a new record.

What does Morepen Laboratories Stock News show today?

Ans. Morepen Laboratories Stock News shows a near 52-week high event with a slight day decline. The key facts are the live price of Rs 120.15, turnover of Rs 8.08 crore and market cap of Rs 6,279.55 crore.

What does Morepen Laboratories Fundamental Analysis suggest?

Ans. Morepen Laboratories Fundamental Analysis shows a P/E of 47.04, P/B of 5.07, ROE of 7.96% and ROCE of 10.19%. EPS is Rs 2.56 and book value per share is Rs 23.78.

How does Morepen Laboratories compare with peers?

Ans. In peer comparison, Morepen Laboratories has a higher P/E than FDC and Innova Captab, but lower than Orchid Pharma and Senores Pharmaceuticals. Its ROE and ROCE are below several peers in the supplied group.

What sector does Morepen Laboratories belong to?

Ans. Morepen Laboratories belongs to Healthcare and the Pharmaceuticals & Drugs industry. The sector dataset covers 199 companies, giving a broad base for valuation and return comparisons. The stock belongs to the Healthcare sector.

How can investors track Morepen Laboratories Share Price on Univest?

Ans. Investors can track Morepen Laboratories Share Price on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels, company financials and Morepen Laboratories Latest News in one place.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Morepen Laboratories Share Price on Univest for live price updates, market capitalisation, valuation ratios, 52-week levels, company financials and broader market insights. Univest also keeps Morepen Laboratories Share Price Today and Morepen Laboratories NSE updates in one place for faster reading.